NRGN and Alzheimer disease: Also, high levels of neurogranin have been reported in cognitively healthy individuals who later experienced a decline in cognition, as well as in healthy older subjects (with a mean age of 83 years) who had low CSF Aβ42 levels, indicative of preclinical AD, compared to those who did not have low CSF Aβ42 levels [65].